<?xml version="1.0" encoding="UTF-8"?>
<ref id="B212-pharmaceuticals-12-00147">
 <label>212.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Leulier</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Marchal</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Miletich</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Limbourg-Bouchon</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Benarous</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Lemaitre</surname>
    <given-names>B.</given-names>
   </name>
  </person-group>
  <article-title>Directed expression of the HIV-1 accessory protein Vpu in 
   <italic>Drosophila</italic> fat-body cells inhibits Toll-dependent immune responses
  </article-title>
  <source>Embo Rep.</source>
  <year>2003</year>
  <volume>4</volume>
  <fpage>976</fpage>
  <lpage>981</lpage>
  <pub-id pub-id-type="doi">10.1038/sj.embor.embor936</pub-id>
  <?supplied-pmid 12973300?>
  <pub-id pub-id-type="pmid">12973300</pub-id>
 </element-citation>
</ref>
